BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx
160 results:

  • 1. Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases.
    Dicks LMT
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674014
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Meningioma: current updates on genetics, classification, and mouse modeling.
    Szulzewsky F; Thirimanne HN; Holland EC
    Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities.
    Ahirwar K; Kumar A; Srivastava N; Saraf SA; Shukla R
    Int J Biol Macromol; 2024 May; 266(Pt 1):131048. PubMed ID: 38522697
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib.
    Cabezas-Camarero S; García-Barberán V; Pérez-Alfayate R; Gómez Del Pulgar ME; Cabrera-Martin MN; Casado-Fariñas I; Pérez-Segura P
    Oncologist; 2024 May; 29(5):377-383. PubMed ID: 38438322
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel BRAF::PTPRN2 fusion in meningioma: a case report.
    Sadagopan NS; Nandoliya KR; Youngblood MW; Horbinski CM; Ahrendsen JT; Magill ST
    Acta Neuropathol Commun; 2023 Dec; 11(1):194. PubMed ID: 38066633
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Increasing Ciliary ARL13B Expression Drives Active and Inhibitor-Resistant smoothened and GLI into Glioma Primary Cilia.
    Shi P; Tian J; Mallinger JC; Ling D; Deleyrolle LP; McIntyre JC; Caspary T; Breunig JJ; Sarkisian MR
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830570
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.
    Youngblood MW; Erson-Omay Z; Li C; Najem H; Coșkun S; Tyrtova E; Montejo JD; Miyagishima DF; Barak T; Nishimura S; Harmancı AS; Clark VE; Duran D; Huttner A; Avşar T; Bayri Y; Schramm J; Boetto J; Peyre M; Riche M; Goldbrunner R; Amankulor N; Louvi A; Bilgüvar K; Pamir MN; Özduman K; Kilic T; Knight JR; Simon M; Horbinski C; Kalamarides M; Timmer M; Heimberger AB; Mishra-Gorur K; Moliterno J; Yasuno K; Günel M
    Nat Commun; 2023 Oct; 14(1):6279. PubMed ID: 37805627
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.
    Kresbach C; Holst L; Schoof M; Leven T; Göbel C; Neyazi S; Tischendorf J; Loose C; Wrzeszcz A; Yorgan T; Rutkowski S; Schüller U
    Neuro Oncol; 2024 Apr; 26(4):609-622. PubMed ID: 37767814
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Classification and Molecular Diagnosis of Benign brain Tumors].
    Yoshimoto K
    No Shinkei Geka; 2023 Sep; 51(5):771-777. PubMed ID: 37743328
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors.
    Di Fiore A; Bellardinelli S; Pirone L; Russo R; Angrisani A; Terriaca G; Bowen M; Bordin F; Besharat ZM; Canettieri G; Fabretti F; Di Gaetano S; Di Marcotullio L; Pedone E; Moretti M; De Smaele E
    Neoplasia; 2023 Sep; 43():100926. PubMed ID: 37597490
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Landscape of Meningiomas.
    Wang JZ; Nassiri F; Mawrin C; Zadeh G
    Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.
    Tonn S; Korshunov A; Obrecht D; Sill M; Spohn M; von Hoff K; Milde T; Pietsch T; Goschzik T; Bison B; Juhnke BO; Struve N; Sturm D; Sahm F; Bockmayr M; Friedrich C; von Bueren AO; Gerber NU; Benesch M; Jones DTW; Kool M; Wefers AK; Schüller U; Pfister SM; Rutkowski S; Mynarek M
    Neuro Oncol; 2023 Aug; 25(8):1518-1529. PubMed ID: 36715306
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Emerging Roles of Hedgehog Signaling in cancer Immunity.
    Giammona A; Crivaro E; Stecca B
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674836
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PRC2 disruption in cerebellar progenitors produces cerebellar hypoplasia and aberrant myoid differentiation without blocking medulloblastoma growth.
    Cleveland AH; Malawsky D; Churiwal M; Rodriguez C; Reed F; Schniederjan M; Velazquez Vega JE; Davis I; Gershon TR
    Acta Neuropathol Commun; 2023 Jan; 11(1):8. PubMed ID: 36635771
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
    Sloan AE; Nock CJ; Ye X; Buerki R; Chang S; Lesser G; Norden A; Cloughesy T; Olson J; Kerstetter-Fogle A; Rich J; Fisher J; Desideri S; Takebe N; Timmer W; Grossman S; Prados M
    J Neurooncol; 2023 Jan; 161(1):33-43. PubMed ID: 36581779
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
    Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
    J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ABT-737 suppresses aberrant Hedgehog pathway and overcomes resistance to smoothened antagonists by blocking Gli.
    Huang W; Liu H; Tan W; Wang J
    Med Oncol; 2022 Sep; 39(12):188. PubMed ID: 36071246
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Druggable UHRF1/DNMT1/GLI Complex Regulates Sonic Hedgehog-Dependent Tumor Growth.
    Yang F; Rodriguez-Blanco J; Long J; Swiderska-Syn M; Wynn DT; Li B; Shen C; Nayak A; Ban Y; Sun X; Suter RK; McCrea HJ; Capobianco AJ; Ayad NG; Robbins DJ
    Mol Cancer Res; 2022 Nov; 20(11):1598-1610. PubMed ID: 35925047
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Noncanonical activation of GLI signaling in SOX2
    Swiderska-Syn M; Mir-Pedrol J; Oles A; Schleuger O; Salvador AD; Greiner SM; Seward C; Yang F; Babcock BR; Shen C; Wynn DT; Sanchez-Mejias A; Gershon TR; Martin V; McCrea HJ; Lindsey KG; Krieg C; Rodriguez-Blanco J
    Sci Adv; 2022 Jul; 8(29):eabj9138. PubMed ID: 35857834
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway.
    Gong W; Zhao W; Liu G; Shi L; Zhao X
    Aging (Albany NY); 2022 Jul; 14(13):5464-5477. PubMed ID: 35802536
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.